These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 16260352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F, Könemann S, Wolff B, Barth S, Staudt A, Kroemer HK, Dahm JB, Felix SB, Landsberger M.
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [Abstract] [Full Text] [Related]

  • 3. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
    Wang S, Jiang JL, Hu CP, Zhang XJ, Yang DL, Li YJ.
    Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
    Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):827-34. PubMed ID: 16139132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
    Myśliwiec M, Balcerska A, Zorena K, Myśliwska J, Lipowski P, Raczyńska K.
    Diabetes Res Clin Pract; 2008 Jan 06; 79(1):141-6. PubMed ID: 17716775
    [Abstract] [Full Text] [Related]

  • 9. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T.
    Metabolism; 2003 May 06; 52(5):605-8. PubMed ID: 12759891
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-alpha-stimulated human endothelial cells.
    Eisenreich A, Boltzen U, Poller W, Schultheiss HP, Rauch U.
    Biol Chem; 2008 Oct 06; 389(10):1333-8. PubMed ID: 18713021
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis.
    Sugano M, Tsuchida K, Makino N.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):872-6. PubMed ID: 10860844
    [Abstract] [Full Text] [Related]

  • 15. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure.
    Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R.
    Circulation; 2004 Sep 07; 110(10):1209-12. PubMed ID: 15249502
    [Abstract] [Full Text] [Related]

  • 16. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
    Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y.
    Metabolism; 2005 Oct 07; 54(10):1297-301. PubMed ID: 16154427
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes.
    Farías M, Puebla C, Westermeier F, Jo MJ, Pastor-Anglada M, Casanello P, Sobrevia L.
    Cardiovasc Res; 2010 Apr 01; 86(1):45-54. PubMed ID: 20032083
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
    Friedl J, Turner E, Alexander HR.
    Int J Oncol; 2003 Sep 01; 23(3):611-6. PubMed ID: 12888895
    [Abstract] [Full Text] [Related]

  • 19. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.
    Diabet Med; 2005 Aug 01; 22(8):999-1004. PubMed ID: 16026364
    [Abstract] [Full Text] [Related]

  • 20. [Interleukin-12, vascular endothelial growth factor and tumor necrosis factor-alpha in the process of neoangiogenesis of diabetic retinopathy in children].
    Zorena K, Myśliwska J, Myśliwiec M, Balcerska A, Lipowski P, Raczyńska K.
    Klin Oczna; 2007 Aug 01; 109(4-6):155-9. PubMed ID: 17725275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.